Episode Details
Back to EpisodesEarly-Stage HER2+ Breast Cancer
Episode 568
Published 9 months, 3 weeks ago
Description
Drs. Lynce and Waks discuss advances in early-stage HER2+ breast cancer, focusing on how targeted therapies have transformed outcomes. They explore de-escalation strategies, the role of platinum drugs, insights from the COMPASS trial, and the importance of pathologic complete response in guiding treatment decisions.